[
  {
    "Index": "1",
    "Result": [
      {
        "evidence": "Recently, metformin, the most widely used first-line drug for diabetes, was found to contain a carcinogenic contaminant known as N-nitroso dimethylamine (NDMA).",
        "bel_statement": "a(CHEBI:metformin) hasComponent a(CHEBI:N,N-dimethyl-4-nitrosoaniline)"
      }
    ]
  },
  {
    "Index": "2",
    "Result": []
  },
  {
    "Index": "3",
    "Result": [
      {
        "evidence": "Phosphorylation at S326 is mediated by AKT1, mTOR, p38, MEK1 and DYRK2.",
        "bel_statement": "act(p(HGNC:AKT1), ma(GO:\"kinase activity\")) directlyIncreases p(HGNC:HSF1, pmod(Ph, Ser, 326))"
      },
      {
        "evidence": "AKT2 also phosphorylated S326 of HSF1 but showed weak ability to activate HSF1.",
        "bel_statement": "act(p(HGNC:AKT2), ma(GO:\"kinase activity\")) directlyIncreases p(HGNC:HSF1, pmod(Ph, Ser, 326))"
      },
      {
        "evidence": "Similarly, mTOR, p38, MEK1 and DYRK2 all phosphorylated S326 but AKT1 was the most potent activator.",
        "bel_statement": "act(p(HGNC:MTOR), ma(GO:\"kinase activity\")) directlyIncreases p(HGNC:HSF1, pmod(Ph, Ser, 326))"
      },
      {
        "evidence": "Similarly, mTOR, p38, MEK1 and DYRK2 all phosphorylated S326 but AKT1 was the most potent activator.",
        "bel_statement": "act(p(FPLX:p38), ma(GO:\"kinase activity\")) directlyIncreases p(HGNC:HSF1, pmod(Ph, Ser, 326))"
      },
      {
        "evidence": "Similarly, mTOR, p38, MEK1 and DYRK2 all phosphorylated S326 but AKT1 was the most potent activator.",
        "bel_statement": "act(p(HGNC:MAP2K1), ma(GO:\"kinase activity\")) directlyIncreases p(HGNC:HSF1, pmod(Ph, Ser, 326))"
      },
      {
        "evidence": "Similarly, mTOR, p38, MEK1 and DYRK2 all phosphorylated S326 but AKT1 was the most potent activator.",
        "bel_statement": "act(p(HGNC:DYRK2), ma(GO:\"kinase activity\")) directlyIncreases p(HGNC:HSF1, pmod(Ph, Ser, 326))"
      },
      {
        "evidence": "Mass spectrometry showed that AKT1 also phosphorylated HSF1 at T142, S230 and T527 in addition to S326, whereas the other kinases did not.",
        "bel_statement": "act(p(HGNC:AKT1), ma(GO:\"kinase activity\")) directlyIncreases p(HGNC:HSF1, pmod(Ph, Thr, 142))"
      },
      {
        "evidence": "Mass spectrometry showed that AKT1 also phosphorylated HSF1 at T142, S230 and T527 in addition to S326, whereas the other kinases did not.",
        "bel_statement": "act(p(HGNC:AKT1), ma(GO:\"kinase activity\")) directlyIncreases p(HGNC:HSF1, pmod(Ph, Ser, 230))"
      },
      {
        "evidence": "Mass spectrometry showed that AKT1 also phosphorylated HSF1 at T142, S230 and T527 in addition to S326, whereas the other kinases did not.",
        "bel_statement": "act(p(HGNC:AKT1), ma(GO:\"kinase activity\")) directlyIncreases p(HGNC:HSF1, pmod(Ph, Thr, 527))"
      }
    ]
  },
  {
    "Index": "4",
    "Result": [
      {
        "evidence": "Consistent with our previous findings, AKT1 strongly induced HSF1 activity (Fig. 1A-C).",
        "bel_statement": "act(p(HGNC:AKT1), ma(GO:\"kinase activity\")) directlyIncreases act(p(HGNC:HSF1))"
      },
      {
        "evidence": "AKT2 promoted a significant increase in HSF1 activity, but the effect was modest while AKT3 had no significant effect on HSF1 activity (Fig. 1A-C).",
        "bel_statement": "act(p(HGNC:AKT2), ma(GO:\"kinase activity\")) directlyIncreases act(p(HGNC:HSF1))"
      },
      {
        "evidence": "Both AKT1 and AKT2 phosphorylated S326 of HSF1 at similar levels but AKT3 showed no capability for phosphorylating S326 (Fig. 1D).",
        "bel_statement": "act(p(HGNC:AKT1), ma(GO:\"kinase activity\")) directlyIncreases p(HGNC:HSF1, pmod(Ph, Ser, 326))"
      },
      {
        "evidence": "Both AKT1 and AKT2 phosphorylated S326 of HSF1 at similar levels but AKT3 showed no capability for phosphorylating S326 (Fig. 1D).",
        "bel_statement": "act(p(HGNC:AKT2), ma(GO:\"kinase activity\")) directlyIncreases p(HGNC:HSF1, pmod(Ph, Ser, 326))"
      }
    ]
  },
  {
    "Index": "5",
    "Result": [
      {
        "evidence": "These results seem contradictory because AKT2 phosphorylated S326, but the level of phosphorylation far exceeded the HSF1 activity induced by AKT2 (Fig. 1A-D).",
        "bel_statement": "act(p(HGNC:AKT2), ma(GO:\"kinase activity\")) directlyIncreases p(HGNC:HSF1, pmod(Ph, Ser, 326))"
      },
      {
        "evidence": "AKT1 is also a well-known activator of mTOR and mTOR has been shown to phosphorylate HSF1 at S326 in response to proteotoxic stress.",
        "bel_statement": "act(p(HGNC:MTOR), ma(GO:\"kinase activity\")) directlyIncreases p(HGNC:HSF1, pmod(Ph, Ser, 326))"
      }
    ]
  },
  {
    "Index": "6",
    "Result": [
      {
        "evidence": "Introduction of AKT1 was observed to promote a significant increase in trimerization, although the AKT1-driven trimerization was not as much as heat stress (Fig. 2A-B).",
        "bel_statement": "p(HGNC:AKT1) increases complex(p(HGNC:HSF1))"
      },
      {
        "evidence": "Similarly, introduction of AKT1 promoted a significant increase of HSF1 binding to putative targets HSPA1A (HSP70), HSPA8 (HSP73) and HSPD1 (HSP60), whereas AKT2 and AKT3 had no significant effect on HSF1 binding (Fig. 2C).",
        "bel_statement": "p(HGNC:AKT1) increases p(HGNC:HSF1, ma(GO:\"DNA binding\"))"
      },
      {
        "evidence": "To confirm whether DNA binding of HSF1 resulted in gene transactivation, we further assessed expression of HSP70 and HSP90, well-known HSF1 target genes, in response to expression of AKT1, AKT2 or AKT3.",
        "bel_statement": "p(HGNC:AKT1) increases bp(GO:\"positive regulation of DNA-templated transcription initiation\")"
      }
    ]
  },
  {
    "Index": "7",
    "Result": []
  },
  {
    "Index": "8",
    "Result": [
      {
        "evidence": "Effects of tripterine were investigated on endothelial barrier function, inducible nitric oxide synthase (iNOS) expression, nicotinamide adenine dinucleotide phosphate (NADPH) oxidase activity, 3-nitrotyrosine formation, protein phosphatase type 2A (PP2A) activity, activation of extracellular-regulated kinase (ERK), c-Jun terminal kinase (JNK) and Janus kinase (Jak2), and degradation of IkB in microvascular endothelial cells exposed to pro-inflammatory stimulus [lipopolysaccharide (LPS) + interferon g (IFNg)] and on vascular permeability in air pouches of mice injected with LPS + IFNg.",
        "bel_statement": "a(CHEBI:celastrol) decreases p(HGNC:NOS2)"
      },
      {
        "evidence": "Effects of tripterine were investigated on endothelial barrier function, inducible nitric oxide synthase (iNOS) expression, nicotinamide adenine dinucleotide phosphate (NADPH) oxidase activity, 3-nitrotyrosine formation, protein phosphatase type 2A (PP2A) activity, activation of extracellular-regulated kinase (ERK), c-Jun terminal kinase (JNK) and Janus kinase (Jak2), and degradation of IkB in microvascular endothelial cells exposed to pro-inflammatory stimulus [lipopolysaccharide (LPS) + interferon g (IFNg)] and on vascular permeability in air pouches of mice injected with LPS + IFNg.",
        "bel_statement": "a(CHEBI:celastrol) decreases act(FPLX:PPP2)"
      },
      {
        "evidence": "Effects of tripterine were investigated on endothelial barrier function, inducible nitric oxide synthase (iNOS) expression, nicotinamide adenine dinucleotide phosphate (NADPH) oxidase activity, 3-nitrotyrosine formation, protein phosphatase type 2A (PP2A) activity, activation of extracellular-regulated kinase (ERK), c-Jun terminal kinase (JNK) and Janus kinase (Jak2), and degradation of IkB in microvascular endothelial cells exposed to pro-inflammatory stimulus [lipopolysaccharide (LPS) + interferon g (IFNg)] and on vascular permeability in air pouches of mice injected with LPS + IFNg.",
        "bel_statement": "a(CHEBI:celastrol) decreases act(FPLX:ERK)"
      },
      {
        "evidence": "Effects of tripterine were investigated on endothelial barrier function, inducible nitric oxide synthase (iNOS) expression, nicotinamide adenine dinucleotide phosphate (NADPH) oxidase activity, 3-nitrotyrosine formation, protein phosphatase type 2A (PP2A) activity, activation of extracellular-regulated kinase (ERK), c-Jun terminal kinase (JNK) and Janus kinase (Jak2), and degradation of IkB in microvascular endothelial cells exposed to pro-inflammatory stimulus [lipopolysaccharide (LPS) + interferon g (IFNg)] and on vascular permeability in air pouches of mice injected with LPS + IFNg.",
        "bel_statement": "a(CHEBI:celastrol) decreases act(FPLX:JNK)"
      },
      {
        "evidence": "Effects of tripterine were investigated on endothelial barrier function, inducible nitric oxide synthase (iNOS) expression, nicotinamide adenine dinucleotide phosphate (NADPH) oxidase activity, 3-nitrotyrosine formation, protein phosphatase type 2A (PP2A) activity, activation of extracellular-regulated kinase (ERK), c-Jun terminal kinase (JNK) and Janus kinase (Jak2), and degradation of IkB in microvascular endothelial cells exposed to pro-inflammatory stimulus [lipopolysaccharide (LPS) + interferon g (IFNg)] and on vascular permeability in air pouches of mice injected with LPS + IFNg.",
        "bel_statement": "a(CHEBI:celastrol) decreases act(HGNC:JAK2)"
      }
    ]
  },
  {
    "Index": "9",
    "Result": [
      {
        "evidence": "The second phase, excision of a short DNA strand segment containing the lesion, is carried out by an assembly of the XPG and XPF:excision repair cross-complementing 1 (ERCC1) endonucleases, together with XPA, RPA, TFIIH, and PCNA (which can bind XPG).",
        "bel_statement": "complex(p(HGNC:ERCC5), p(HGNC:ERCC4), p(HGNC:ERCC1), p(HGNC:XPA), p(FPLX:RPA), p(HGNC:GTF2H3), p(HGNC:PCNA))"
      }
    ]
  },
  {
    "Index": "10",
    "Result": []
  },
  {
    "Index": "11",
    "Result": [
      {
        "evidence": "Kinases DYRK1A and DYRK3 have been shown to phosphorylate human SIRT1 at T522, stimulating the deacetylation of p53 by SIRT1; phosphorylation at this site increases the rate of product release by SIRT1.",
        "bel_statement": "act(p(HGNC:DYRK1A), ma(GO:\"kinase activity\")) directlyIncreases p(HGNC:SIRT1, pmod(Ph, Thr, 522))"
      },
      {
        "evidence": "Kinases DYRK1A and DYRK3 have been shown to phosphorylate human SIRT1 at T522, stimulating the deacetylation of p53 by SIRT1; phosphorylation at this site increases the rate of product release by SIRT1.",
        "bel_statement": "act(p(HGNC:DYRK3), ma(GO:\"kinase activity\")) directlyIncreases p(HGNC:SIRT1, pmod(Ph, Thr, 522))"
      },
      {
        "evidence": "AMPK phosphorylates human SIRT1 at T344 inhibiting its ability to decacetylate p53, a known target of SIRT1.",
        "bel_statement": "act(p(FPLX:AMPK), ma(GO:\"kinase activity\")) directlyIncreases p(HGNC:SIRT1, pmod(Ph, Thr, 344))"
      },
      {
        "evidence": "Sumoylation at K734 by SUMO1 increases, whereas desumoylation by SENP1 decreases, the activity of SIRT1 in response to genotoxic stress.",
        "bel_statement": "p(HGNC:SIRT1, pmod(Sumo, Lys, 734)) increases act(p(HGNC:SIRT1))"
      },
      {
        "evidence": "Sumoylation at K734 by SUMO1 increases, whereas desumoylation by SENP1 decreases, the activity of SIRT1 in response to genotoxic stress.",
        "bel_statement": "act(p(HGNC:SUMO1), ma(\"GO:SUMO transferase activity\")) directlyIncreases act(p(HGNC:SIRT1))"
      },
      {
        "evidence": "Sumoylation at K734 by SUMO1 increases, whereas desumoylation by SENP1 decreases, the activity of SIRT1 in response to genotoxic stress.",
        "bel_statement": "act(p(HGNC:SENP1), ma(\"GO:protein desumoylation\")) directlyDecreases act(p(HGNC:SIRT1))"
      }
    ]
  },
  {
    "Index": "12",
    "Result": [
      {
        "evidence": "Three of the sirtuins, SIRT1, SIRT6, and SIRT7 localize to the nucleus, SIRT2 is mainly localized in the cytoplasm, while the remaining three sirtuins: SIRT3, SIRT4, and SIRT5 are found in the mitochondria.",
        "bel_statement": "p(HGNC:SIRT1) localizes GO:nucleus"
      },
      {
        "evidence": "Three of the sirtuins, SIRT1, SIRT6, and SIRT7 localize to the nucleus, SIRT2 is mainly localized in the cytoplasm, while the remaining three sirtuins: SIRT3, SIRT4, and SIRT5 are found in the mitochondria.",
        "bel_statement": "p(HGNC:SIRT6) localizes GO:nucleus"
      },
      {
        "evidence": "Three of the sirtuins, SIRT1, SIRT6, and SIRT7 localize to the nucleus, SIRT2 is mainly localized in the cytoplasm, while the remaining three sirtuins: SIRT3, SIRT4, and SIRT5 are found in the mitochondria.",
        "bel_statement": "p(HGNC:SIRT7) localizes GO:nucleus"
      },
      {
        "evidence": "Three of the sirtuins, SIRT1, SIRT6, and SIRT7 localize to the nucleus, SIRT2 is mainly localized in the cytoplasm, while the remaining three sirtuins: SIRT3, SIRT4, and SIRT5 are found in the mitochondria.",
        "bel_statement": "p(HGNC:SIRT2) localizes GO:cytoplasm"
      },
      {
        "evidence": "Three of the sirtuins, SIRT1, SIRT6, and SIRT7 localize to the nucleus, SIRT2 is mainly localized in the cytoplasm, while the remaining three sirtuins: SIRT3, SIRT4, and SIRT5 are found in the mitochondria.",
        "bel_statement": "p(HGNC:SIRT3) localizes GO:mitochondrion"
      },
      {
        "evidence": "Three of the sirtuins, SIRT1, SIRT6, and SIRT7 localize to the nucleus, SIRT2 is mainly localized in the cytoplasm, while the remaining three sirtuins: SIRT3, SIRT4, and SIRT5 are found in the mitochondria.",
        "bel_statement": "p(HGNC:SIRT4) localizes GO:mitochondrion"
      },
      {
        "evidence": "Three of the sirtuins, SIRT1, SIRT6, and SIRT7 localize to the nucleus, SIRT2 is mainly localized in the cytoplasm, while the remaining three sirtuins: SIRT3, SIRT4, and SIRT5 are found in the mitochondria.",
        "bel_statement": "p(HGNC:SIRT5) localizes GO:mitochondrion"
      },
      {
        "evidence": "SIRT1 and SIRT5 are primarily protein deacetylases, SIRT4 and SIRT6 are mono(ADP)-ribosyltransferases, and SIRT2 and SIRT3 exhibit both enzymatic activities; no clear functionality has been attributed to SIRT7.",
        "bel_statement": "act(p(HGNC:SIRT1), ma(GO:\"deacetylase activity\"))"
      },
      {
        "evidence": "SIRT1 and SIRT5 are primarily protein deacetylases, SIRT4 and SIRT6 are mono(ADP)-ribosyltransferases, and SIRT2 and SIRT3 exhibit both enzymatic activities; no clear functionality has been attributed to SIRT7.",
        "bel_statement": "act(p(HGNC:SIRT5), ma(GO:\"deacetylase activity\"))"
      },
      {
        "evidence": "SIRT1 and SIRT5 are primarily protein deacetylases, SIRT4 and SIRT6 are mono(ADP)-ribosyltransferases, and SIRT2 and SIRT3 exhibit both enzymatic activities; no clear functionality has been attributed to SIRT7.",
        "bel_statement": "act(p(HGNC:SIRT4), ma(GO:\"ADP-ribosyltransferase activity\"))"
      },
      {
        "evidence": "SIRT1 and SIRT5 are primarily protein deacetylases, SIRT4 and SIRT6 are mono(ADP)-ribosyltransferases, and SIRT2 and SIRT3 exhibit both enzymatic activities; no clear functionality has been attributed to SIRT7.",
        "bel_statement": "act(p(HGNC:SIRT6), ma(GO:\"ADP-ribosyltransferase activity\"))"
      },
      {
        "evidence": "SIRT1 and SIRT5 are primarily protein deacetylases, SIRT4 and SIRT6 are mono(ADP)-ribosyltransferases, and SIRT2 and SIRT3 exhibit both enzymatic activities; no clear functionality has been attributed to SIRT7.",
        "bel_statement": "act(p(HGNC:SIRT2), ma(GO:\"deacetylase activity\"))"
      },
      {
        "evidence": "SIRT1 and SIRT5 are primarily protein deacetylases, SIRT4 and SIRT6 are mono(ADP)-ribosyltransferases, and SIRT2 and SIRT3 exhibit both enzymatic activities; no clear functionality has been attributed to SIRT7.",
        "bel_statement": "act(p(HGNC:SIRT2), ma(GO:\"ADP-ribosyltransferase activity\"))"
      },
      {
        "evidence": "SIRT1 and SIRT5 are primarily protein deacetylases, SIRT4 and SIRT6 are mono(ADP)-ribosyltransferases, and SIRT2 and SIRT3 exhibit both enzymatic activities; no clear functionality has been attributed to SIRT7.",
        "bel_statement": "act(p(HGNC:SIRT3), ma(GO:\"deacetylase activity\"))"
      },
      {
        "evidence": "SIRT1 and SIRT5 are primarily protein deacetylases, SIRT4 and SIRT6 are mono(ADP)-ribosyltransferases, and SIRT2 and SIRT3 exhibit both enzymatic activities; no clear functionality has been attributed to SIRT7.",
        "bel_statement": "act(p(HGNC:SIRT3), ma(GO:\"ADP-ribosyltransferase activity\"))"
      },
      {
        "evidence": "This review will focus on SIRT1 (EC 3.5.1.-) a member of the sirtuin family that is expressed in many tissues and acts as a NAD+-dependent protein deacetylase.",
        "bel_statement": "act(p(HGNC:SIRT1), ma(GO:\"deacetylase activity\"))"
      }
    ]
  },
  {
    "Index": "13",
    "Result": [
      {
        "evidence": "NF-kappaB signaling exerts anti-apoptotic and cyto-protective properties, which is illustrated by many genetic in vivo models, in which deficiency of central pathway constituents, such as TAK1, IKKss, and IKKgamma induced massive hepatocellular cell death (Luedde and Schwabe,).",
        "bel_statement": "p(HGNC:MAP3K7) decreases bp(GO:\"apoptotic process\")"
      },
      {
        "evidence": "NF-kappaB signaling exerts anti-apoptotic and cyto-protective properties, which is illustrated by many genetic in vivo models, in which deficiency of central pathway constituents, such as TAK1, IKKss, and IKKgamma induced massive hepatocellular cell death (Luedde and Schwabe,).",
        "bel_statement": "p(HGNC:IKBKG) decreases bp(GO:\"apoptotic process\")"
      },
      {
        "evidence": "Interestingly, previous experiments demonstrated that TNF activated NF-kappaB and JNK signaling with different dynamics (Iqbal and Zaidi,)",
        "bel_statement": "act(p(HGNC:TNF)) increases act(FPLX:NFkappaB)"
      }
    ]
  },
  {
    "Index": "14",
    "Result": [
      {
        "evidence": "Biological functions of TNF and subsequent activation of the NF-kappaB signaling pathway are associated with inflammatory processes, hepatocyte proliferation in response to acute or chronic liver damage, as well as tumorigenesis (DiDonato et al.,).",
        "bel_statement": "p(HGNC:TNF) increases act(p(FPLX:NFkappaB))"
      }
    ]
  },
  {
    "Index": "15",
    "Result": [
      {
        "evidence": "A20 suppresses apoptotic JNK signaling in a TNF-dependent and independent manner via induction of ASK1 degradation (Won et al.,).",
        "bel_statement": "p(HGNC:TNFAIP3) directlyDecreases act(p(HGNC:MAP3K5))"
      },
      {
        "evidence": "ASK1 can phosphorylate JNK and the physical interaction between A20 and ASK1 has been demonstrated (Tobiume et al.,; Won et al.,).",
        "bel_statement": "p(HGNC:MAP3K5) directlyIncreases act(p(FPLX:JNK))"
      }
    ]
  },
  {
    "Index": "16",
    "Result": [
      {
        "evidence": "Once the C1 complex is bound to the cell surface, the proteases are activated and are able to cleave another complement protein, C4 into the anaphylatoxin C4a and C4b.",
        "bel_statement": "complex(p(FPLX:C1q), p(HGNC:C1R), p(HGNC:C1R)) directlyIncreases act(p(HGNC:C4A), ma(GO:\"serine-type endopeptidase activity\"))"
      },
      {
        "evidence": "This cleavage causes a large conformational change in C4b, allowing it to covalently bind to cell surfaces and bind another complement protein, C2.",
        "bel_statement": "p(HGNC:C4B) directlyIncreases complex(p(HGNC:C4B), p(HGNC:C2))"
      },
      {
        "evidence": "The complex of C4b and C2a (C4b2a) is a serine protease that specifically cleaves C3 into the anaphylatoxin C3a and the active form of C3, C3b, which is then able to covalently bind to the cell surfaces.",
        "bel_statement": "complex(p(HGNC:C4B), p(HGNC:C2)) directlyIncreases act(p(HGNC:C3), ma(GO:\"serine-type endopeptidase activity\"))"
      }
    ]
  },
  {
    "Index": "17",
    "Result": [
      {
        "evidence": "For example, in the fluid phase, factor H can bind to C3b, preventing the formation of the C3 convertase.",
        "bel_statement": "p(HGNC:CFH) directlyDecreases complex(p(HGNC:C3), p(HGNC:C3))"
      },
      {
        "evidence": "Once bound to see C3b, factor H serves as a co-factor, allowing another compliment protein, factor I, to cleave C3b, thus inactivating it.",
        "bel_statement": "p(HGNC:CFH) directlyIncreases act(p(HGNC:CFI), ma(GO:\"peptidase activity\"))"
      }
    ]
  },
  {
    "Index": "18",
    "Result": [
      {
        "evidence": "After ligation, C3 deposition was seen at the injury site, as well as in areas near the injury site, while no deposition was seen on sham-operated animals (no partial ligation).",
        "bel_statement": "a(GO:\"complement activation\") increases a(HGNC:C3)"
      },
      {
        "evidence": "Injection of IgG, which also activates complement, into the paws of rats caused neuropathic pain symptoms.",
        "bel_statement": "a(GO:\"IgG immunoglobulin complex\") increases a(GO:\"complement activation\")"
      },
      {
        "evidence": "Injection of IgG, which also activates complement, into the paws of rats caused neuropathic pain symptoms.",
        "bel_statement": "a(GO:\"complement activation\") increases a(EFO:neuropathic pain)"
      },
      {
        "evidence": "These rats also showed less C3 deposition and macrophage influx.",
        "bel_statement": "a(GO:\"complement activation\") increases a(HGNC:C3)"
      }
    ]
  },
  {
    "Index": "19",
    "Result": [
      {
        "evidence": "In this study, we report that SLAMF1 is required for Toll-like receptor 4 (TLR4)-mediated induction of interferon beta (IFNbeta) and for killing of Gram-negative bacteria by human macrophages.",
        "bel_statement": "p(HGNC:SLAMF1) directlyIncreases p(HGNC:TLR4)"
      },
      {
        "evidence": "We found that endogenous SLAMF1 protein interacted with TRAM and defined key interaction domains as amino acids 68 to 95 of TRAM as well as 15 C-terminal amino acids of SLAMF1.",
        "bel_statement": "p(HGNC:SLAMF1) directlyIncreases p(HGNC:TICAM2)"
      }
    ]
  },
  {
    "Index": "20",
    "Result": [
      {
        "evidence": "This results in an immediate activation of nuclear factor kappaB (NF-kappaB) and production of proinflammatory cytokines.",
        "bel_statement": "p(HGNC:TLR4) directlyIncreases act(FPLX:NFkappaB)"
      }
    ]
  }
]